Implantable medical device batteries market seen reaching $1.6 billion by 2030

Global demand for implantable medical device batteries is rising as more patients rely on pacemakers, neurostimulators and other implanted devices. The market is projected to grow from $1.12 billion in 2025 to $1.6 billion by 2030, with North America leading today and Asia-Pacific set to grow fastest.

Why it matters: - Implantable medical device batteries are a core input for devices that support long-term treatment inside the human body. - Stronger demand for these batteries reflects rising use of pacemakers, implantable cardioverter defibrillators, deep brain stimulators and neurostimulators. - Growth in this market tracks broader pressure from cardiovascular and neurological disease, plus an aging population.

What happened: - The Business Research Company released its Implantable Medical Device Batteries Global Market Report 2026. - The market is projected to grow from $1.12 billion in 2025 to $1.21 billion in 2026. - The report puts 2025-2026 growth at a 7.7% CAGR. - The market is forecast to reach $1.6 billion by 2030. - The report is available as a free sample here. - The full report is available here.

The details: - The report cites rising adoption of implantable medical devices as a key historical driver. - Demand for durable power sources is increasing as device makers prioritize battery reliability and safety. - Advanced neurostimulation devices are one of the main drivers of future growth. - Miniaturized implantable batteries are becoming more important as devices shrink. - Rechargeable battery technology continues to advance. - Higher energy density remains a major design target. - Next-generation implantable drug delivery systems are adding to demand. - Implantable medical device batteries are designed for high energy density, consistent discharge, long-term stability and hermetic sealing. - These batteries must perform reliably over long periods inside the human body. - The report flags high-energy-density batteries, long-life primary battery technologies, miniaturization, hermetically sealed designs and stable power output as key trends. - North America was the largest regional market in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report’s market package includes TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables.

Between the lines: - The market’s growth is being shaped less by consumer adoption and more by the clinical need for dependable power in high-stakes implants. - Battery performance is becoming a product differentiator because device failure risk, size constraints and longevity requirements all matter at once. - The strong outlook for Asia-Pacific suggests the next wave of growth may come from broader healthcare access and rising chronic disease burdens outside mature U.S. and European markets. - The NIH projected in August 2025 that cardiovascular disease prevalence would rise 90% between 2025 and 2050, with deaths increasing from 20.5 million to 35.6 million over the same period.

What's next: - Demand is likely to keep rising as neurostimulation, drug delivery and other implantable systems become more advanced. - Battery makers are expected to keep pushing smaller form factors, higher energy density and longer life. - Regional growth will likely remain uneven, with North America retaining a large base and Asia-Pacific expanding faster.

The bottom line: - Implantable medical device batteries are moving from a niche component to a faster-growing strategic market as chronic disease, aging populations and smaller, more capable implants drive demand.